ref | material | application | target | method | |
---|---|---|---|---|---|
17 | MoO3–x NUs | biodegradation-medicated enzymatic activity-tunable molybdenum oxide nanourchins (MoO3–x NUs), which selectively perform therapeutic activity in tumor microenvironment via cascade catalytic reactions, while keeping normal tissues unharmed due to their responsive biodegradation in physiological environment | |||
35 | Cu5.4O USNPs | exhibit cytoprotective effects against ROS-mediated damage at extremely low dosage and significantly improve treatment outcomes in acute kidney injury, acute liver injury and wound healing. | |||
36 | P-Co3O4 | Detection of H2O2 and Glucose | GSH | Color | |
36 | P-Co3O4 | Detection of H2O2 and Glucose | H2O2 | Color | |
36 | R-Co3O4 | Detection of H2O2 and Glucose | GSH | Color | |
36 | R-Co3O4 | Detection of H2O2 and Glucose | H2O2 | Color | |
66 | Fe3O4 NP | Colorimetric quantification of phenol | Phenol | Color | |
73 | vanadium oxide nanodots (VOxNDs) | Antibacterial | |||
95 | Co3O4 | Detection of S. aureus | S. aureus | Color | |
101 | CeO2 NPs | protection from DEN-induced liver damage via antioxidative activity. | |||
109 | IrOx | demonstrate for the first time that iridium oxide nanoparticles (IrOx) possess acid-activated oxidase and peroxidase-like functions and wide pH-dependent catalase-like properties. Integrating of glucose oxidase (GOD) could unlock its oxidase and peroxidase activities by gluconic acid produced by catalysis of GOD towards glucose in cancer cells, and the produced H2O2 can be converted to O2 to compensate its consumption in GOD catalysis due to the catalase-like function of the nanozyme, which result in continual consumption of glucose and self-supplied substrates for generating superoxide anion and hydroxyl radical. | |||
112 | Cerium Oxide Nanoparticles | More studies looking into the therapeutic effects of cerium oxide nanoparticles in systemic conditions caused inter alia by oxidative stress, inflammation, and bacteria. Therapeutic effects of these nanoparticles in diseases that require tissue regeneration (scaffolds) need to be further explored | |||
149 | NiO | detection of P(III) | P(III) | Fluor | |
150 | Co3O4 NPs | detection of L-Ascorbic acid | L-Ascorbic acid | Color | |
150 | Co3O4@β-CD NPs | detection of L-Ascorbic acid | L-Ascorbic acid | Color | |
150 | Co3O4@β-CD NPs | detection of L-Ascorbic acid | L-Ascorbic acid | Color | |
165 | VONP-LPs | Above results confirmed the ultra sensitivity and excellent specificity of the VONP-LPs based dual-modality biosensor proving applicability of developed sensor for real samples (Fig. 5b). To confirm the practicability real clinical samples are examined. Different types of clinical NoV (GII. 2, GII. 3, GII.4) from human feces of infected patients are detected using the developed dual-modality sensor | NoV-LPs and clinical samples | Color | |
165 | VONP-LPs | To determine the linear range and sensitivity of the developed dualmodality sensor, different concentrations of NoV-LPs are examined. Anti-NoV antibody-conjugated VONP-LPs, MNPs and aliquot of NoV-LPs with various concentrations are mixed. VONP-LPs and the MNPs are bound with NoV-LPs through the specific interaction with antibody on their surface and a nanoconjugate of VONP-LPs, NoV-LPs and MNPs is formed. | NoV-LPs | Color | |
173 | MoO3 NPs | Acid phosphatase (ACP) catalyzes the hydrolysis of the ascorbic acid 2-phosphate (AAP) substrate to produce ascorbic acid (AA). AAwas found to fade the coloration process of the MoO3 NP-mediated ABTS oxidation. By combining the oxidase-mimicking property of the MoO3 NPs and the ACP-catalyzed hydrolysis ofAAP, a novel and simple colorimetric method for detecting ACP was established | Acid phosphatase (ACP) | Color | |
182 | T-BiO2–x NSs | overcome the hypoxia-induced radioresistance as well as increase the efficacy of RT |